Haemonetics 1st Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website
Haemonetics Corporation (NYSE: HAE) released its financial results for Q1 FY23, ending July 2, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Haemonetics Corporation (NYSE: HAE) released its financial results for Q1 FY23, ending July 2, 2022. The results and additional analytical information are available on the company's Investor Relations website. A conference call is scheduled for August 10, 2022, at 8:00 a.m. EDT to discuss these results with investors and analysts. Participants can access the call via a teleconference link or live webcast. Earnings release and supplemental documents related to the quarter were also posted online for detailed review.
Details
News Market Reaction – HAE
The recorded move for HAE in the trading session of this news was +8.89%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Financial release accessible online
BOSTON, Aug. 10, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal 2023, which ended July 2, 2022, are available on its Investor Relations website.
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. EDT on August 10, 2022. The conference call and webcast can be accessed with the following information:
- Teleconference link: https://register.vevent.com/register/BI722ba0e696e749e6b514af4c2a3d3cc1
- Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
- A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/dc896g7s
In addition, the Company has posted to its Investor Relations website the earnings release and analytical tables and supplemental information that will be referenced on its conference call and webcast, direct links to which are available below.
Direct link to 1Q FY23 Earnings Release:
https://haemonetics.gcs-web.com/static-files/28d85dc8-1d09-4355-937b-0cc17f6d51a5
Direct link to 1Q FY23 Analytical Tables and Supplemental Information:
https://haemonetics.gcs-web.com/static-files/4abb751e-3eb6-41a8-a06b-b3c48ba9d5c9
A replay of the conference call and webcast will be available for one year beginning on August 10, 2022, at 11:00 a.m. EDT using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | |
Olga Guyette, Sr. Director-Investor Relations & Treasury | David Trenk, Manager-Investor Relations |
(781) 356-9763 | (203) 733-4987 |
Media Contact: | |
Josh Gitelson, Director-Global Communications | |
(781) 356-9776 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-1st-quarter-fiscal-year-2023-earnings-release-available-on-investor-relations-website-301602928.html
SOURCE Haemonetics Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.